These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35956066)

  • 1. Anatomical and Functional Effects of Oral Administration of Curcuma Longa and Boswellia Serrata Combination in Patients with Treatment-Naïve Diabetic Macular Edema.
    Guarino O; Iovino C; Di Iorio V; Rosolia A; Schiavetti I; Lanza M; Simonelli F
    J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35956066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography classifications of diabetic macular edema and response to aflibercept: One-year follow-up outcomes in a Chinese population.
    Gu Z; Xi T; Zhang C; Yang G
    Medicine (Baltimore); 2023 Jan; 102(4):e32815. PubMed ID: 36705371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
    Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
    BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in choroidal thickness after anti-vascular endothelial growth factor treatment of diabetic macular edema, real-life data, 2-year results.
    Savur F; Kaldırım H; Atalay K; Korkmaz Ş
    Cutan Ocul Toxicol; 2021 Dec; 40(4):326-331. PubMed ID: 34275395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and anatomic results of up to 24 months aflibercept treatment for diabetic macular edema in real-life setting.
    Tsapardoni FN; Makri OE; Lagogiannis AP; Tsekouras IK; Chairas N; Pallikari A; Pagoulatos DD; Georgakopoulos CD
    Hell J Nucl Med; 2019; 22 Suppl 2():47-54. PubMed ID: 31802045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHANGES IN CENTRAL CHOROIDAL THICKNESS AFTER TREATMENT OF DIABETIC MACULAR EDEMA WITH INTRAVITREAL BEVACIZUMAB CORRELATION WITH CENTRAL MACULAR THICKNESS AND BEST-CORRECTED VISUAL ACUITY.
    Nourinia R; Ahmadieh H; Nekoei E; Malekifar P; Tofighi Z
    Retina; 2018 May; 38(5):970-975. PubMed ID: 28426622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity.
    Sacconi R; Battaglia Parodi M; Casati S; Lattanzio R; Marchini G; Bandello F
    Ophthalmic Res; 2017; 58(3):125-130. PubMed ID: 28704825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic macular edema in proliferative stage treated with anti-vascular endothelial growth factor agent and triamcinolone acetonide by laser-based strategies.
    Qiao G; Dong WJ; Dai Y; Jiang ZH; Guo HK
    Int J Ophthalmol; 2017; 10(7):1113-1119. PubMed ID: 28730115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Abo-Elenin M
    Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of combined phacoemulsification and intravitreal injection of bevacizumab in prevention of postoperative macular edema in non-proliferative diabetic retinopathy.
    Khodabandeh A; Fadaifard S; Abdollahi A; Karkhaneh R; Roohipoor R; Abdi F; Ghasemi H; Habibollahi S; Mazloumi M
    J Curr Ophthalmol; 2018 Sep; 30(3):245-249. PubMed ID: 30197955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of metformin treatment with enhanced effect of anti-VEGF agents in diabetic macular edema patients.
    Shao Y; Wang M; Zhu Y; Li X; Liu J
    Acta Diabetol; 2022 Apr; 59(4):553-559. PubMed ID: 35034186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of morphological characteristics of diabetic macular edema in patients with non-proliferative versus proliferative diabetic retinopathy: a spectral-domain optical coherence tomography study.
    Chatziralli I; Theodossiadis G; Dimitriou E; Theodossiadis P
    Int Ophthalmol; 2021 Jul; 41(7):2417-2424. PubMed ID: 33772414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema.
    Lee HY; Lee SY; Park JS
    Korean J Ophthalmol; 2009 Sep; 23(3):153-8. PubMed ID: 19794940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [No Abstract]   [Full Text] [Related]  

  • 15. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.
    Bahrami B; Hong T; Zhu M; Schlub TE; Chang A
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1133-1140. PubMed ID: 28238195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema].
    Yang XL; Zou HD; Xu X
    Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1081-8. PubMed ID: 24499694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interdigitation and Ellipsoid Zones Disruption Correlate with Visual Outcomes among Treatment-Naive Patients with Diabetic Macular Edema.
    Sharef N; Kassem R; Hecht I; Bar A; Maharshak I; Burgansky-Eliash Z; Weinberger Y; Tuuminen R; Achiron A
    Ophthalmic Res; 2021; 64(3):476-482. PubMed ID: 33221809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to Achieve Near-Normal Visual Acuity with Bevacizumab in Diabetic Macular Edema Patients.
    Sędziak-Marcinek B; Wylęgała A; Chełmecka E; Wylęgała E; Teper S
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to Initial Anti-Vascular Endothelial Growth Factor for Diabetic Macular Edema Is Significantly Correlated with Response to Third Consecutive Monthly Injection.
    Maeda S; Sugimoto M; Tenma Y; Tsukitome H; Kato K; Chujo S; Matsui Y; Matsubara H; Kondo M
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study.
    Bonini-Filho M; Costa RA; Calucci D; Jorge R; Melo LA; Scott IU
    Am J Ophthalmol; 2009 Jun; 147(6):1022-30, 1030.e1-5. PubMed ID: 19327746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.